Abstract
Primary ovarian insufficiency (POІ) is a spectrum of diseases that affect female fertility, contribute to morbidity and mortality, and are associated with increasing estrogen deficiency. Primary ovarian failure, with a prevalence now approaching 4%, is a growing public health problem. POI affects mental health, fertility, cardiovascular health and bone health. Although there is no consensus on the criteria for evaluating POI, it is important to screen any woman with primary or secondary amenorrhea. Primary amenorrhea is defined as the absence of menstruation throughout life unless menarche occurs before age 15 or three years after thelarche. Secondary amenorrhea is defined as the absence of menses for three consecutive months after previously regular menses or the absence of menses for 6 consecutive months with previously irregular menses. POI is diagnosed on the background of amenorrhea with two elevated FSH values in the menopausal range (>25 IU/L), obtained at an interval of 30 days. This article describes the definition, principles of diagnosis and management of primary ovarian insufficiency.
References
Щорічний звіт про стан здоров’я населення України та епідемічну ситуацію за 2022 рік. Київ, 2023.
Уніфікований клінічний протокол первинної, вторинної (спеціалізованої), третинної (високоспеціалізованої) медичної допомоги «Менопаузальні порушення та інші розлади в перименопаузальному періоді». Наказ МОЗ України від 17.06.2022 № 1039. Київ. 2022. Код доступу: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-17062022-1039
Ajmal N, Khan SZ, Shaikh R. Polycystic ovary syndrome (PCOS) and genetic predisposition: A review article. Eur J Obstet Gynecol Reprod Biol X. 2019 Jul;3:100060. [PMC free article] [PubMed]
Anagnostis P, Christou K, Artzouchaltzi AM, et al. Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and metaanalysis. Eur J Endocrinol. 2019;180(1):41-50.
Ates S, Yesil G, Sevket O, et al. Comparison of metabolic profile and abdominal fat distribution between karyotypically normal women with premature ovarian insufficiency and age matched controls. Maturitas. 2014;79(3):306-310.
Baber RJ, N. Panay, A. Fenton, IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016; (19):109-150.
Brand JS, van der Schouw YT, Onland-Moret NC, et al. Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPICInterAct study. Diabetes Care. 2013;36(4):1012-1019.
De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet. 2010 Sep 11;376(9744):911-21. [PubMed]
Dragojević Dikić S, Vasiljević M, Jovanović A, Dikić S, Jurišić A, Srbinović L, Vujović S. Premature ovarian insufficiency — novel hormonal approaches in optimizing fertility. Gynecol Endocrinol. 2020 Feb;36(2):162-165. [PubMed]
Gulhan I, Bozkaya G, Uyar I, et al. Serum lipid levels in women with premature ovarian failure. Menopause. 2012;19(11):1231-1234.
Gunning MN, Meun C, van Rijn BB, et al. Coronary artery calcification in middle-aged women with premature ovarian insufficiency. Clin Endocrinol (Oxf). 2019;91(2):314-322.
Gunning MN, Meun C, van Rijn BB, et al. The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: a case-control study. PLoS One. 2020;15(3):e0229576.
Kalantaridou S, Panay N. Premature ovarian insufficiency: a toolkit for the primary care physician, Climacteric. 2021;24(5):425-437. DOI: 10.1080/13697137.2020.1859246
Klein DA, Paradise SL, Reeder RM. Amenorrhea: A Systematic Approach to Diagnosis and Management. Am Fam Physician. 2019 Jul 01;100(1):39-48. [PubMed]
Knauff EA, Westerveld HE, Goverde AJ, et al. Lipid profile of women with premature ovarian failure. Menopause. 2008;15(5):919-923.
